Global Computed Tomography (CT) Market Trends and Insights
Technological Advances in Detector Design & Iterative Reconstruction
Iterative reconstruction and new detector materials let clinicians achieve sub-millisievert studies while preserving diagnostic quality, cutting dose by up to 60%. Silicon photomultipliers boost photon-detection efficiency, and 0.25 mm elements now resolve coronary stents previously invisible on legacy systems.Rising Global Burden of Oncology & Cardiovascular Diseases
Cancer and cardiovascular disease caused 31 million deaths in 2024, more than half of global mortality, driving sustained CT demand for screening, staging, and perfusion studies. In oncology, the National Comprehensive Cancer Network revised its lung-cancer screening guidelines in 2024 to recommend annual low-dose CT for adults aged 50 to 80 with a 20 pack-year smoking history, expanding the eligible U.S. population from 8 million to 14.5 million individualsHigh Capital & Lifecycle Costs of Premium CT Systems
Photon-counting or dual-energy scanners list between USD 1.8 million and USD 3.5 million, and tube replacements can exceed USD 250,000, steering price-sensitive buyers toward mid-slice or refurbished units.Other drivers and restraints analyzed in the detailed report include:
- Expansion of High-Slice & Spectral CT in Emerging Economies
- AI-Enabled Workflow Automation
- Radiation-Dose Safety Concerns & Tightening Regulations
Segment Analysis
Hardware represented 63.52% of computed tomography market revenue in 2025, but services are set to outpace with a 9.35% CAGR, reflecting hospitals’ preference for uptime guarantees and software subscriptions. Maintenance contracts deliver 35%-45% gross margins, compared with 20%-25% on hardware. Predictive maintenance programs cut downtime by 30%, reinforcing the annuity stream.Services now absorb rising demand for iterative reconstruction upgrades, cybersecurity patches, and regulatory audits. Combined, these factors underline why vendors treat services as the anchor of the computed tomography market.
Mid-slice platforms held 44.11% of computed tomography market share in 2025, but high-slice models will grow 10.46% annually as oncology and trauma protocols demand sub-millimeter resolution. High-slice scanners complete whole-body trauma scans in under 10 seconds, crucial for unstable patients.
Low-slice units are declining except in biopsy suites and dental practices, while cone-beam CT is carving out a niche in orthopedics thanks to compact footprints and lower cost. The computed tomography market size for high-slice platforms is projected to rise sharply once photon-counting becomes mainstream.
Complete Report Scope:
- By Component
- Hardware Systems
- Software & AI Algorithms
- Services (Installation, Maintenance, Up-grades)
- By Slice Count
- Low-slice (Less than 16) CT
- Mid-slice (16-64) CT
- High-slice (More than 64) CT
- Cone Beam CT
- By Technology
- Dual-Energy / Spectral CT
- Photon-Counting CT
- Iterative Reconstruction CT
- AI-integrated CT
- By Modality
- Stationary CT
- Portable CT
- Hybrid PET-CT / SPECT-CT
- By Application
- Oncology
- Cardiology
- Neurology
- Musculoskeletal & Trauma
- Vascular & Others
- By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical & Specialty Centers
- By Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
- South America
- Brazil
- Argentina
- Rest of South America
- North America
Geography Analysis
North America contributed 36.16% of computed tomography market revenue in 2025, supported by favorable reimbursement and the continent’s dense imaging network. The average installed scanner age reached 9.2 years in 2024, indicating pending replacement demand.Asia-Pacific is the growth engine, expanding at an 8.04% CAGR as China’s health commission directs USD 12 billion toward 3,000 county-hospital installations and India’s Ayushman Bharat boosts diagnostic coverage. Local vendors United Imaging and Mindray undercut Western prices by up to 40%, accelerating penetration.
Europe shows moderate growth as MDR dose rules raise compliance costs. Germany earmarked EUR 1.2 billion for upgrades tied to dose-reduction targets, and the UK allocated GBP 400 million to cut imaging backlogs. Latin America and the Middle East showcase faster upticks from infrastructure drives in Saudi Arabia and Brazil, though currency risk tempers some procurements.
List of Companies Covered in this Report:
- Canon
- Carestream Health
- CurveBeam AI
- FUJIFILM
- GE Healthcare
- Koning
- Koninklijke Philips
- MARS BioImaging
- Mindray Medical
- MinFound Medical
- Neusoft
- Planmed
- Samsung NeuroLogica
- Shenzhen Anke Hi-Tech
- Shimadzu
- Siemens Healthineers
- United Imaging Healthcare
- Xoran Technologies
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Canon Medical Systems
- Carestream Health
- CurveBeam AI
- Fujifilm Healthcare
- GE HealthCare
- Koning Corporation
- Koninklijke Philips N.V
- MARS BioImaging
- Mindray Medical
- MinFound Medical
- Neusoft Medical
- Planmed
- Samsung NeuroLogica
- Shenzhen Anke Hi-Tech
- Shimadzu Corporation
- Siemens Healthineers
- United Imaging Healthcare
- Xoran Technologies

